Name (Synonyms) | Correlation | |
---|---|---|
HP:0001626 | Abnormality of the cardiovascular system HPO | 0.21 |
There is one clinical trial.
This study aims to investigate the clinical characteristics, the incidence of myocardial injury, and the influence of myocardial injury on the prognosis in COVID-19 patients. There is no additional examination and treatment for this project.
Description: The myocardial injury incidence of COVID-19 patients
Measure: The myocardial injury incidence Time: 75 daysDescription: The risk factors analysis for the death of COVID-19 patients
Measure: The risk factors analysis for the death Time: 75 daysDescription: The clinical characteristics description of COVID-19 patients
Measure: Clinical characteristics Time: 75 daysDescription: The clinical course description of COVID-19 patients
Measure: Clinical course Time: 75 daysDescription: The clinical characteristics and prognosis analysis in different cardiovascular comorbidity of COVID-19 patients
Measure: Cardiovascular comorbidity Time: 75 daysDescription: Analysis of causes of death in COVID-19 patients
Measure: Analysis of causes of death Time: 75 days